NCT00050986 2020-09-22
Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
M.D. Anderson Cancer Center
Phase 1/2 Completed
Clinical Trials
3 trialsNCT00005859 2018-06-26
Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Completed
NCT00361088 2013-11-25
A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Terminated